Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors

Journal of Urology

Volumn 159, Issue 3, 1998, Pages 783-787

  Colombo, Renzo ^a   Da Pozzo, Luigi Filippo ^a   Lev, Avigdor ^a   Salonia, Andrea ^a   Rigatti, Patrizio ^a   Leib, Zvi ^a   Servadio, Ciro ^a   Caldarera, Emanuele ^a   Pavone Macaluso, Michele ^a  

^a NONE

Author keywords

Bladder; Bladder neoplasms; Chemotherapy; Microwaves

Indexed keywords

ANTINEOPLASTIC AGENT; MITOMYCIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER TUMOR; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; HYPERTHERMIC THERAPY; INTRAVESICAL DRUG ADMINISTRATION; MALE; MICROWAVE RADIATION; PRIORITY JOURNAL; RASH; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

EID: 0031906267     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63728-5     Document Type: Article

References (41)

1. Lutzeyer, W., Rubben, H. and Daham, H.: Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J. Urol., 127: 250, 1982.
2. Heney, N. M., Ahmed, S., Flanigan, M. J., Frable, W., Corder, M. P., Hafermann, M. D. and Hawkins, I. R. for the National Bladder Cancer Collaborative Group A: Superficial bladder cancer: progression and recurrence. J. Urol., 130: 1083, 1983.
3. Smith, G., Elton, R. A., Chisholm, G. D., Newsam, J. E. and Hargreave, T. B.: Superficial bladder cancer: intravesical chemotherapy and tumor progression to muscle invasion or metastases. Brit. J. Urol., 58: 659, 1986.
4. Hahn, G. M.: Potential for theraphy of drugs and hyperthermia. Cancer Res., 39: 2264, 1979.
5. Marmor, J. B.: Interactions of hyperthermia and chemotherapy in animals. Cancer Res., part. 2, 39: 2269, 1979.
6. Roizin-Towle, L., Hall, E. J. and Capuano, L.: Interaction of hyperthermia and cytotoxic agents. Nat. Cancer Inst. Monogr., 61: 149, 1982.
7. Nakajima, K. and Hisazumi, H.: Enhanced radioinduced cytotoxicity of cultured human bladder cancer cells using 43 degrees C hyperthermia or anticancer drugs. Urol. Res., 15: 255, 1987.
8. Overgaard, J.: The rationale for clinical trials. In: Practical Aspects of Clinical Hyperthermia. Edited by S. B. Field and J. W. Hand. London: Taylor and Francis, pp. 213-241, 1990.
9. Colombo, R., Lev, A., Da Pozzo, L., Freschi, M., Gallus, G. and Rigatti, P.: A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment. J. Urol., 153: 959, 1995.
10. Colombo, R., Da Pozzo, L. F., Lev, A., Freschi, M., Gallus, G. and Rigatti, P.: Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer. J. Urol., 155: 1227, 1996.
11. Rigatti, P., Lev, A. and Colombo, R.: Combined intravesical chemotherapy with mytomycin C and local bladder microwave-induced hyperthermia as a preoperative therapy for superficial bladder tumors. A preliminary clinical study. Eur. Urol., 20: 204, 1991.
12. Colombo, R., Da Pozzo, L. F., Lev, A., Freschi, M. and Rigatti, P.: Neoadjuvant combined local hyperthermia and topical chemotherapy for superficial bladder cancer. Preliminary results. J. Urol., part 2, 151: 474A, abstract, 986, 1994.
13. Malkowicz, S. B., Nichols, P., Lieskovsky, G., Boyd, S. D., Huffman, J. and Skinner, D. G.: The role of radical cystectomy in the management of high grade superficial bladder cancer. J. Urol., 144: 641, 1990.
14. Zhang, G. K., Uke, E. T., Sharer, W. C., Borkon, W. D. and Bernstein, S. M.: Reassessment of conservative management for stage T1N0M0 transitional cell carcinoma of the bladder. J. Urol., 155: 1907, 1996.
15. Pansadoro, V., Emiliozzi, P., Defidio, L., Donadio, D., Florio, A., Maurelli, S. and Stenberg, C. N.: Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder. Long-term results. J. Urol., 154: 2054, 1995.
16. Sugimachi, K., Inokuchi, K., Kai, H., Ueo, H., Kuwano, H. and Matsufuji, H.: Preoperative hyperthermo-chemo-radiotherapy effective for carcinoma of the esophagus. J. Surg. Oncol., 4: 27, 1984.
17. Koga, S., Hamazoe, R., Maeta, M., Shimizu, N., Murakami, A. and Wakatsuki, T.: Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer, 61: 232, 1988.
18. Arcangeli, G., Cividalli, A., Mauro, F., Nervi, C. and Pavin, G.: Enhanced effectiveness of adriamycin and bleomycin combined with local hyperthermia in neck node metastases from head and neck cancers. Tumori, 65: 481, 1979.
19. Longo, F. W., Tomashefsky, P., Rivin, B. D. and Tannenbaum, M.: Interaction of ultrasonic hyperthermia with two alkylating agents in a murine bladder tumor. Cancer Res., 43: 3231, 1983.
20. Haas, G. P., Klugo, R. C., Hetzel, F. W., Barton, E. E. and Cerny, J. C.: The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinoma. J. Urol., 132: 132, 1984.
21. Herman, T. S., Teicher, B. A., Jochelson, M., Clark, J., Svensson, G. and Coleman, C. N.: Rationale for the use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. Int. J. Hyperthermia, 4: 143, 1988.
22. Hall, H. H., Schade, R. O. K. and Swinny, J.: Effect of hyperthermia on bladder cancer. Brit. Med. J., 2: 593, 1974.
23. Hall, R. R., Wadehra, V., Towler, J. M., Hindmarsh, J. R. and Byrne, P. O.: Hyperthermia in the treatment of bladder tumors. Brit. J. Urol., 48: 603, 1976.
24. Ludgate, C. M., McLean, N., Carswell, G. F., Newsam, J. E., Pettigrew, R. T. and Tulloch, W. S.: Hyperthermic perfusion of the distended bladder in the management of recurrent transitional cell carcinoma. Brit. J. Urol., 47: 841, 1975.
25. England, H. R., Anderson, J. D., Minasian, H., Marshall, V. R., Molland, E. A. and Blandy, J. P.: The therapeutic application of hyperthermia in the bladder. Brit. J. Urol., 47: 849, 1976.
26. Nishimura, K., Ogawa, O., Yoshimura, N., Nakagawa, T. and Sasaki, M.: Effect of hyperthermic irrigation with bleomycin on prophylaxis of recurrence of bladder cancer. Hinyokika Kiyo, 31: 769, 1985.
27. Nakajima, K., Hisazumi, H., Kumaki, O. and Ueki, O.: Inhibition of cell growth by irradiation in combination with hyperthermia or anticancer drugs. Acta Rad. Oncol., 22: 487, 1983.
28. Nakajima, K., Hisazumi, H., Misaki, T., Kawaguchi, K., Sugata, T., Kameda, K., Ueki, O., Miyagi, T. and Nishino, A.: A hyperthermic perfusion therapy using peplomycin and ethanol for bladder cancer. Hinyokika Kiyo, 30: 1421, 1984.
29. Van der Meijden, A. P. M., Hall, R. R., Pavone-Macaluso, M., Pawinsky, A., Sylvester, R. and Van Glabbeke, M.: Marker tumor response to the sequential combination of intravesical therapy with mitomycin C and BCG-RIVM in multiple superficial bladder tumors. Report from the European Organisation for Research and Treatment of Cancer Genito-urinary Group (EORTC 30897). Eur. Urol., 29: 199, 1996.
30. Braken, R. B., Swanson, D. A., Johnoson, D. E., De Furia, D., Eschenbach, A. C. and Crooke, S.: Role of intravesical mitomycin C in management of superficial bladder tumors. Urology, 16: 11, 1980.
31. Bouffioux, C., van der Meijden, A., Kurth, K. H., Jakse, G., Bono, A., Hall, R., Oosterling, W. and Sylvester, R.: Objective response of superficial bladder tumors to intravesical treatment (including review of response of marker lesions). In: European Organisation for Research and Treatment of Cancer Genitourinary Group Monographe 11: Recent Progress in Bladder and Kidney Cancer. New York: Wiley-Liss, Inc., pp. 29-42, 1992.
32. Richie, J. P.: Intravesical chemotherapy, treatment selection, techniques and results. Urol. Clin. N. Amer., 19: 521, 1992.
33. Maffezzini, M., Simonato, A., Zanon, M., Raber, M. and Carmignani, R.: Up-front intravesical chemotherapy for low stage, low grade recurrent bladder cancer. J. Urol., 155: 91, 1996.
34. Jauhianen, K., Kangas, L., Kapyla, H. and Alfthan, O.: Intravesical cytostatics: pH-dependence of antitumor activity. Urol. Res., 13: 19, 1985.
35. Wientjes, M. G., Badalament, R. A. and Au, J. L.-S.: Use of pharmacological data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer. Cancer Chemother. Pharmacol., 32: 255, 1993.
36. Dalton, J. T., Wientjes, M. G., Badalament, R. A., Drago, J. R. and Au, J. L.-S.: Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer. Cancer Res., 51: 5144, 1991.
37. Wientjes, M. G., Badalament, R. A., Hassan, F., Drago, J. R. and Au, J. L.-S.: Factors influencing bladder wall concentration during intravesical cancer chemotherapy. Proc. Amer. Ass. Cancer Res., 33: 556, 1992.
38. Watanabe, H., Nako, M., Nakagawa, S. and Takada, H.: Size and location of tumors influencing the effect of bladder instillation therapy. Cancer Chemother. Pharmacol., 20: 348, 1987.
39. Huland, H., Kloppel, G., Feddersen, I., Otto, U., Brachmann, W., Hubmann, H., Kaufmann, J., Knipper, W., Lantzius-Beninga, F. and Huland, E.: Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicentric study with 419 patients. J. Urol., 144: 1107, 1990.
40. Isaka, S., Okano, T., Shimazaki, J., Igarashi, T., Marakami, S., Higa, T., Ishikawa, T., Zama, S., Kataumi, S. and Kataumi, Z.: Prophylaxis of superficial bladder cancer with instillation of adriamycin or mitomycin C. Cancer Chemother. Pharmacol., 20: 77, 1987.
41. Matzkin, H., Rangel, M. C. and Soloway, M. S.: In vitro study of the effect of hyperthermia on normal bladder line and on five different transitional cell carcinoma cell lines. J. Urol., 147: 1671, 1992.